In addition, we showed that citromycin inhibited the invasion of ovarian cancer cells by downregulating the EMT marker gene expression levels and MMP2/9 activation via the ERK signaling pathway (Figure S5). The gene discussed is MMP2; the disease is ovarian carcinoma.